Literature DB >> 6168366

Serous ovarian neoplastic amylase (SONA): a potentially useful marker for serous ovarian tumors.

H Van Kley, S Cramer, D E Bruns.   

Abstract

A series of cystic ovarian tumors was studied with regard to amylase activity in the cyst fluid. Large amounts of amylase activity were present only in those patients with endosalpingeal-type lining epithelium (serous ovarian neoplasms). The amylase activity from two such patients was further characterized using G75 Sephadex chromatography, DEAE Sephadex chromatography, agarose gel chromatography, isoelectric focusing, and heat inactivation studies. Serous ovarian neoplastic amylase (SONA) exhibited properties different from amylases of pancreatic and salivary gland origin. Serous ovarian neoplastic amylase (SONA) may be a pancreatic and salivary gland origin. Serous ovarian neoplastic amylase (SONA) may be a useful biochemical marker in diagnosing and managing patients with serous ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168366     DOI: 10.1002/1097-0142(19810915)48:6<1444::aid-cncr2820480628>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancer.

Authors:  R Osborne; B Evans; C Gallagher; C Wood; M Slevin; J Shepherd; E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Use of amylase isoenzymes in laboratory evaluation of hyperamylasemia.

Authors:  D M Jensen; V L Royse; J N Bonello; J Schaffner
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

3.  Amylase levels in pleural and peritoneal fluid in Meigs' syndrome.

Authors:  J N Simson
Journal:  J R Soc Med       Date:  1987-10       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.